Related Experiment Video
Updated: Jun 30, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Crohn's disease--defect in innate defence
Michael Gersemann1, Jan Wehkamp, Klaus Fellermann
1Internal Medicine I, Robert Bosch Hospital, Auerbachstrasse 110, Stuttgart, Germany.
Crohn's disease involves defects in the gut's innate immune system, specifically the antimicrobial barrier. This leads to reduced alpha- and beta-defensins, allowing microbes to trigger inflammation in the ileum and colon.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Crohn's disease affects the entire gastrointestinal tract, commonly the small intestine and colon.
- Its pathogenesis involves complex defects in innate immunity, particularly the mucosal antimicrobial barrier.
Purpose of the Study:
- To investigate the molecular mechanisms of innate immune defects in Crohn's ileitis and colitis.
- To identify specific antimicrobial peptide deficiencies contributing to Crohn's disease phenotypes.
Main Methods:
- Analysis of Wnt signaling pathway transcription factor TCF4 expression in Crohn's ileitis.
- Assessment of alpha-defensins (HD5, HD6) and beta-defensins (HBD2, HBD3) expression in ileal and colonic tissues.
- Investigation of beta-defensin gene copy numbers in Crohn's colitis.
Main Results:
- Crohn's ileitis shows reduced TCF4 expression, leading to deficient alpha-defensins (HD5, HD6) from Paneth cells.
- Crohn's colitis is linked to impaired beta-defensin (HBD2, HBD3) induction due to fewer gene copies.
- These deficiencies in innate defense peptides may allow microbial invasion and inflammation.
Conclusions:
- Defects in alpha- and beta-defensins are key molecular mechanisms in ileal and colonic Crohn's disease.
- Understanding these innate immune deficits offers potential for new therapies.
- Stimulating the protective innate immune system presents a novel therapeutic strategy for Crohn's disease.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations